James Kihara Insider Trades & Stock Holdings

PRINCIPAL ACCOUNTING OFFICER · ACADIA Pharmaceuticals Inc. · Latest filing Jun 26, 2026

James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA Pharmaceuticals Inc. has 1 Form 4 trade on file since Jun 26, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($297.86K), net -$297.86K. Latest filing: disposed of 11.42K shares of $ACAD on Jun 26, 2026 at $26.08.

Trades on file

1

Open-market bought

$0

Open-market sold

$297.86K

Net open-market

-$297.86K

Latest filing

Jun 26, 2026

All insider trades by James Kihara

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 26, 2026	$ACAD	Sell (Open-market sale) 10b5-1	11.42K	$26.08	$297.86K			+1.8%	+0.3%		PRINCIPAL ACCOUNTING OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks James Kihara traded

• $ACAD

Frequently asked questions

Has James Kihara been buying or selling stock?

James Kihara has 0 open-market purchases and 1 open-market sale on file, net -$297.86K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was James Kihara's latest insider trade?

disposed of 11.42K shares of $ACAD on Jun 26, 2026 at $26.08.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.